What is the treatment for croup?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Croup

Administer oral dexamethasone 0.15-0.6 mg/kg (maximum 10-12 mg) as a single dose to all children with croup regardless of severity, and add nebulized epinephrine for moderate to severe cases. 1, 2

Initial Management by Severity

Mild Croup

  • Give oral dexamethasone 0.15-0.6 mg/kg (maximum 10-12 mg) as a single dose 1, 3
  • Observe for 2-3 hours to ensure symptoms are improving 2
  • No nebulized treatments are needed for mild cases 2
  • Avoid routine imaging unless concerned about alternative diagnoses like bacterial tracheitis or foreign body aspiration 1

Moderate to Severe Croup

  • Administer oral dexamethasone 0.15-0.6 mg/kg (maximum 10-12 mg) PLUS nebulized epinephrine 1, 2
  • Nebulized epinephrine dose: 0.5 mL/kg of 1:1000 solution (maximum 5 mL) 1, 2
  • Observe for at least 2 hours after each epinephrine dose due to short-lived effect (1-2 hours) and risk of rebound symptoms 1, 2
  • Provide supplemental oxygen via nasal cannula, head box, or face mask to maintain oxygen saturation >94% 1

Hospitalization Decision-Making

Consider admission after 3 doses of nebulized epinephrine rather than the traditional 2 doses—this approach reduces hospitalization rates by 37% without increasing revisits or readmissions 4, 1, 2. Recent evidence from the American Academy of Pediatrics supports this more conservative admission threshold 2.

Additional admission criteria include:

  • Oxygen saturation <92% 1
  • Age <18 months 1
  • Respiratory rate >70 breaths/min 1
  • Persistent difficulty breathing despite treatment 1

Critical Pitfalls to Avoid

Never discharge a patient within 2 hours of receiving nebulized epinephrine—the rebound phenomenon is real and dangerous 1, 2. This is the most common error in croup management.

Other key pitfalls:

  • Do not withhold corticosteroids in mild cases—all severities benefit from dexamethasone 1, 2
  • Do not use nebulized epinephrine in outpatient settings where adequate observation cannot be ensured 1, 2
  • Avoid antibiotics—croup is viral and antibiotics provide no benefit 1
  • Do not rely on humidified air or cold air therapy, which lack evidence of efficacy 1, 5

Alternative Corticosteroid Options

While oral dexamethasone is preferred, nebulized budesonide 2 mg is equally effective and may be used when oral administration is not feasible 4, 6. However, oral dexamethasone remains the preferred route due to ease of administration 7.

Discharge Criteria

Patients may be discharged when they demonstrate:

  • Resolution of stridor at rest 1, 2
  • Minimal or no respiratory distress 1, 2
  • Adequate oral intake 1, 2
  • Parents understand warning signs and when to return 1, 2

Provide clear return precautions: instruct parents to return immediately for worsening stridor, increased work of breathing, or inability to maintain hydration 1. If not improving after 48 hours, the child should be reviewed by their primary care provider 1.

Supportive Care

  • Use antipyretics for comfort 1
  • Minimize handling to reduce metabolic and oxygen requirements 1
  • Ensure adequate hydration 8
  • Do not use antihistamines or decongestants—they have no proven benefit in viral croup 8

References

Guideline

Treatment of Croup in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Croup with Nebulization

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Croup: an overview.

American family physician, 2011

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical inquiries. What's best for croup?

The Journal of family practice, 2011

Research

Current pharmacological options in the treatment of croup.

Expert opinion on pharmacotherapy, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.